Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of BMS-686117 in subjects with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-686117

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED